CPMD

$0.00-25.00%visit website

CANNAPHARMARX, INC.

Market Cap

$1M

Live price × SEC shares (Aug 18, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

2.62

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.6

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	657	139	627	276	1,699
Cost of revenue	1,097	660	1,037	415	3,208
Gross profit	(440)	(521)	(409)	(138)	(1,509)
Total operating expenses	496	372	273	240	1,381
Operating income	(936)	(894)	(682)	(379)	(2,890)
Interest expense	506	179	476	349	1,510
Pretax income				(1,909)
Income tax				0.00
Net income	(1,478)	(7,550)	(382)	(1,909)	(11,318)
EPS (basic) ($)				0.00
EPS (diluted) ($)	0.00		0.00	0.00	(0.02)
Weighted avg. shares (basic)	662,501			682,482
Weighted avg. shares (diluted)			669,790	682,482

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 18, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 62 more quarters, back to Mar 2010, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jan 13, 2026 accepted 7:02 PM ET	5.02Officer / director change8.01Other events	Document SEC ↗
Dec 18, 2025 accepted 7:47 PM ET	8.01Other events	Document SEC ↗
Oct 10, 2025 accepted 11:53 AM ET	8.01Other events	Document SEC ↗
May 6, 2025 accepted 1:58 PM ET	8.01Other events	Document SEC ↗
Mar 31, 2025 accepted 8:39 AM ET	5.02Officer / director change	Document SEC ↗
Dec 3, 2024 accepted 6:24 PM ET	4.01Auditor change	Document SEC ↗
Nov 21, 2024 accepted 1:47 PM ET	4.01Auditor change	Document SEC ↗